Technology | Antiplatelet and Anticoagulation Therapies | July 14, 2016

BBMK Technologies Launches ClotMD Mobile App for Real-time Warfarin Management

Application sends real-time alerts on INR levels, scheduled testing and medication reminders to improve patient compliance

BBMK Technologies, ClotMD mobile app, real-time warfarin management

July 14, 2016 — BBMK Technologies recently announced the launch of ClotMD, a cloud-based application and mobile solution. The software-as-a-service (SaaS)-based solution allows healthcare providers to overcome the challenges of managing patients on anticoagulant medication, specifically warfarin.

Healthcare providers can easily manage on-site testing or home INR monitoring while enhancing patient medication adherence and improving their business. With ClotMD, providers have access to a fully integrated warfarin monitoring solution, allowing patients to engage actively in their health for an improved outcome on any computer or mobile device.

Patients who are on warfarin to manage anticoagulation require consistent and ongoing testing of INR levels to maintain within therapeutic range and avoid potentially serious health implications. ClotMD is designed to help healthcare providers manage their warfarin patient population while improving day-to-day business processes. Providers can now focus on patients who require their attention when they fall outside of target therapeutic range or are non-compliant with prescribed medication and/or testing.

The app works on any computer or mobile device, providing a real-time connection between providers and patients. ClotMD allows for convenient management of INR levels, dosing calculations and testing schedules.

The ClotMD mobile app makes patient-centric care possible by delivering real-time alerts on INR levels, scheduled testing and medication reminders.  Further, patients can also receive automatic notifications from their healthcare provider alerting them to a warfarin dosage change. A built-in diet library offers another layer of support for patients who want to be proactive regarding their health. History of current and previous INR levels can be tracked and shared by the patient.

For more information: www.clotmd.com

Related Content

COMPASS Trial Shows Rivaroxaban With Aspirin Improves Stable Cardiovascular Disease
Feature | Antiplatelet and Anticoagulation Therapies| September 12, 2017
September 12, 2017 — Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with
Text Messaging Could Help Tackle High Blood Pressure in At-Risk Patients

Image courtesy of Michigan Medicine

News | Hypertension| September 06, 2017
A new National Institutes of Health-funded hypertension trial will examine the possibility of using an emergency...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Real-World Analysis Compares Safety, Effectiveness of Apixaban Versus Warfarin
News | Antiplatelet and Anticoagulation Therapies| August 28, 2017
August 28, 2017 — Bristol-Myers Squibb Company and Pfizer Inc.
MDISS Launches 'WHISTL' Network of Medical Device Security Testing Labs
News | Cybersecurity| August 23, 2017
The Medical Device Innovation, Safety and Security Consortium (MDISS) recently launched the first of more than a dozen...
HHS Unveils Improved Web Tool to Highlight Recent Health Information Breaches
News | Cybersecurity| August 21, 2017
The U.S. Department of Health and Human Services (HHS), Office for Civil Rights (OCR) recently launched a revised web...
Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
Healthcare cybersecurity concerns have increased dramatically as EMRs and medical devices become more digitally connected.

Healthcare cybersecurity concerns have increased dramatically as EMRs and medical devices become more digitally connected.

Feature | Cybersecurity| August 18, 2017 | Dave Fornell
August 17, 2017 — Cybersecurity has become a growing concern in healthcare as patient data, medical systems and impla
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Overlay Init